Heterogeneity and Architecture of Pathological Prion Protein Assemblies: Time to Revisit the Molecular Basis of the Prion Replication Process?

Animals Humans Neurodegenerative Diseases / genetics PrPC Proteins / chemistry PrPSc Proteins / chemistry Protein Folding
PrP amyloid dynamics prion quasi-species

Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
10 05 2019
Historique:
received: 17 04 2019
revised: 07 05 2019
accepted: 08 05 2019
entrez: 15 5 2019
pubmed: 15 5 2019
medline: 25 7 2020
Statut: epublish

Résumé

Prions are proteinaceous infectious agents responsible for a range of neurodegenerative diseases in animals and humans. Prion particles are assemblies formed from a misfolded, β-sheet rich, aggregation-prone isoform (PrP

Identifiants

DOI: 10.3390/v11050429 PMID: 31083283 PMC: PMC6563208
pubmed: 31083283
pii: v11050429
doi: 10.3390/v11050429
pmc: PMC6563208
pii:
doi:

Substances chimiques

PrPC Proteins 0
PrPSc Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Références

Cell Mol Neurobiol. 2000 Dec;20(6):717-30
pubmed: 11100979
Annu Rev Neurosci. 2001;24:519-50
pubmed: 11283320
EMBO J. 2001 Apr 2;20(7):1547-54
pubmed: 11285219
Biochemistry. 2002 Oct 22;41(42):12868-75
pubmed: 12379130
Brain. 2003 Sep;126(Pt 9):2065-73
pubmed: 12821516
Genetics. 2003 Sep;165(1):23-33
pubmed: 14504215
Br Med Bull. 2003;66:99-108
pubmed: 14522852
Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2293-8
pubmed: 14983003
Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8342-7
pubmed: 15155909
Science. 2004 Jun 18;304(5678):1793-7
pubmed: 15155912
J Biol Chem. 2004 Jul 30;279(31):32354-9
pubmed: 15173173
Proc Natl Acad Sci U S A. 2004 Aug 17;101(33):12271-6
pubmed: 15302929
PLoS Biol. 2004 Oct;2(10):e321
pubmed: 15383837
J Neurochem. 2005 Jan;92(1):132-42
pubmed: 15606903
Proc Natl Acad Sci U S A. 2005 May 24;102(21):7535-40
pubmed: 15894615
J Virol. 2005 Aug;79(16):10796-806
pubmed: 16051871
Nature. 2005 Sep 8;437(7056):257-61
pubmed: 16148934
Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):16031-6
pubmed: 16239348
Curr Opin Struct Biol. 2005 Dec;15(6):724-30
pubmed: 16263262
Nature. 2006 Aug 3;442(7102):585-9
pubmed: 16810177
Mol Cell. 2006 Aug 4;23(3):425-38
pubmed: 16885031
J Virol. 2007 Jan;81(2):835-43
pubmed: 17079295
Proc Natl Acad Sci U S A. 2006 Dec 12;103(50):19105-10
pubmed: 17142317
Biochemistry. 2006 Dec 26;45(51):15710-7
pubmed: 17176093
PLoS Pathog. 2007 Aug 31;3(8):e125
pubmed: 17784787
J Virol. 2007 Dec;81(24):13794-800
pubmed: 17913812
Science. 2007 Nov 9;318(5852):930-6
pubmed: 17991853
Proc Natl Acad Sci U S A. 2007 Nov 27;104(48):18946-51
pubmed: 18025469
Vet Res. 2008 Jul-Aug;39(4):47
pubmed: 18519020
Biochem J. 2008 Dec 1;416(2):297-305
pubmed: 18684106
PLoS Comput Biol. 2009 Jul;5(7):e1000420
pubmed: 19578427
Proc Natl Acad Sci U S A. 2009 Oct 6;106(40):16990-5
pubmed: 19805070
Acc Chem Res. 2010 Feb 16;43(2):271-9
pubmed: 19817406
Science. 2010 Feb 12;327(5967):869-72
pubmed: 20044542
FASEB J. 2010 Sep;24(9):3222-31
pubmed: 20410442
PLoS Pathog. 2010 Apr 15;6(4):e1000859
pubmed: 20419156
Science. 2010 May 28;328(5982):1154-8
pubmed: 20466881
Neurobiol Dis. 2011 Jan;41(1):219-25
pubmed: 20875860
Biochemistry. 2010 Nov 9;49(44):9488-97
pubmed: 20925423
J Virol. 2011 Feb;85(3):1174-81
pubmed: 21084466
Nature. 2011 Feb 24;470(7335):540-2
pubmed: 21350487
Cold Spring Harb Perspect Biol. 2011 Jan 01;3(1):a006833
pubmed: 21421910
PLoS Pathog. 2011 Mar;7(3):e1001317
pubmed: 21437239
Nat Struct Mol Biol. 2011 Apr;18(4):504-6
pubmed: 21441913
PLoS Pathog. 2011 Mar;7(3):e1001319
pubmed: 21445238
Biochemistry. 2011 Sep 20;50(37):7933-40
pubmed: 21848309
EMBO Rep. 2011 Oct 28;12(11):1109-17
pubmed: 21997298
Science. 2012 Jan 27;335(6067):472-5
pubmed: 22282814
PLoS Pathog. 2012 Feb;8(2):e1002522
pubmed: 22319450
PLoS Pathog. 2012;8(3):e1002547
pubmed: 22396643
Nat Struct Mol Biol. 2012 Apr 04;19(4):370-7
pubmed: 22472622
PLoS Pathog. 2012;8(8):e1002835
pubmed: 22876179
PLoS Pathog. 2013;9(10):e1003702
pubmed: 24130496
PLoS Pathog. 2013;9(12):e1003759
pubmed: 24339773
MBio. 2013 Dec 31;5(1):e00829-13
pubmed: 24381300
J Clin Invest. 2014 Feb;124(2):847-58
pubmed: 24430187
Nat Commun. 2014 Jul 09;5:4347
pubmed: 25005024
J Biol Chem. 2014 Aug 29;289(35):24129-42
pubmed: 25028516
Sci Rep. 2015 May 07;5:10062
pubmed: 25950908
J Biol Chem. 2015 Aug 14;290(33):20417-26
pubmed: 26126829
MBio. 2015 Sep 22;6(5):e01419-15
pubmed: 26396245
Acta Neuropathol Commun. 2016 Feb 05;4:10
pubmed: 26847207
Sci Rep. 2016 Feb 15;6:20526
pubmed: 26877167
Open Biol. 2016 May;6(5):
pubmed: 27249641
Sci Rep. 2016 Jul 07;6:29116
pubmed: 27384922
PLoS Pathog. 2016 Sep 08;12(9):e1005835
pubmed: 27606840
R Soc Open Sci. 2016 Aug 3;3(8):160235
pubmed: 27853598
Cold Spring Harb Perspect Biol. 2017 Sep 1;9(9):null
pubmed: 28096267
Nat Commun. 2017 Jan 23;8:14170
pubmed: 28112164
PLoS Pathog. 2017 Apr 13;13(4):e1006229
pubmed: 28406976
Acta Neuropathol Commun. 2017 Apr 21;5(1):32
pubmed: 28431576
PLoS Pathog. 2017 Sep 7;13(9):e1006557
pubmed: 28880932
Pathogens. 2018 Feb 07;7(1):null
pubmed: 29414853
Brain Pathol. 2018 Nov;28(6):999-1011
pubmed: 29505163
Nat Rev Mol Cell Biol. 2018 Dec;19(12):755-773
pubmed: 30237470
Am J Pathol. 2019 Jun;189(6):1276-1283
pubmed: 30926338
PLoS Pathog. 2019 Apr 10;15(4):e1007712
pubmed: 30970042
Virology. 1988 Jun;164(2):537-41
pubmed: 3130718
J Virol. 1978 Mar;25(3):933-5
pubmed: 417194
Biochem Biophys Res Commun. 1966 Feb 3;22(3):278-84
pubmed: 4957205
Nature. 1967 Sep 2;215(5105):1043-4
pubmed: 4964084
Nature. 1969 Apr 5;222(5188):90-1
pubmed: 4975649
Nature. 1970 Sep 26;227(5265):1341-3
pubmed: 4989433
J Comp Pathol. 1971 Jul;81(3):383-91
pubmed: 4998373
Science. 1982 Apr 9;216(4542):136-44
pubmed: 6801762
Neuron. 1995 Nov;15(5):1183-91
pubmed: 7576660
Virology. 1976 Mar;70(1):230-7
pubmed: 816078
J Virol. 1996 Mar;70(3):1714-22
pubmed: 8627692
Chem Biol. 1996 Jun;3(6):413-4
pubmed: 8807870
EMBO J. 1997 Oct 15;16(20):6057-65
pubmed: 9321385
Chem Biol. 1995 Jan;2(1):1-5
pubmed: 9383397

Auteurs

Angélique Igel-Egalon (A)

Molecular Virology and Immunology Unit (VIM), INRA, Université Paris-Saclay, 78350 Jouy-en-Josas, France. angelique.egalon@inra.fr.

Jan Bohl (J)

Molecular Virology and Immunology Unit (VIM), INRA, Université Paris-Saclay, 78350 Jouy-en-Josas, France. jan.bohl@u-psud.fr.
Laboratory of Physical Chemistry (LCP), UMR 8000 CNRS, Université Paris Sud, 91400 Orsay, France. jan.bohl@u-psud.fr.

Mohammed Moudjou (M)

Molecular Virology and Immunology Unit (VIM), INRA, Université Paris-Saclay, 78350 Jouy-en-Josas, France. mohammed.moudjou@inra.fr.

Laetitia Herzog (L)

Molecular Virology and Immunology Unit (VIM), INRA, Université Paris-Saclay, 78350 Jouy-en-Josas, France. laetitia.herzog@inra.fr.

Fabienne Reine (F)

Molecular Virology and Immunology Unit (VIM), INRA, Université Paris-Saclay, 78350 Jouy-en-Josas, France. fabienne.reine@inra.fr.

Human Rezaei (H)

Molecular Virology and Immunology Unit (VIM), INRA, Université Paris-Saclay, 78350 Jouy-en-Josas, France. human.rezaei@inra.fr.

Vincent Béringue (V)

Molecular Virology and Immunology Unit (VIM), INRA, Université Paris-Saclay, 78350 Jouy-en-Josas, France. vincent.beringue@inra.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Heterogeneity and Architecture of Pathological...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Heterogeneity and Architecture of Pathological...
questionsmedicales.fr › Maladies du système nerveux › Maladies neurodégénératives › Heterogeneity and Architecture of Pathological...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Prions › Protéines prion › Protéines PrPC › Heterogeneity and Architecture of Pathological...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Prions › Protéines prion › Protéines PrPSc › Heterogeneity and Architecture of Pathological...
questionsmedicales.fr › Phénomènes chimiques › Phénomènes biochimiques › Pliage des protéines › Heterogeneity and Architecture of Pathological...